Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Differential Maturation of Mir-17 ~ 92 Cluster Members in Human Cancer Cell Lines Publisher Pubmed



Abasi M1, 2, 4 ; Kohram F4, 5 ; Fallah P6 ; Arashkia A7 ; Soleimani M8 ; Zarghami N1, 9 ; Ghanbarian H2, 3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Medical Biotechnology, Faculty of Advanced Medical Science, Tabriz University of Medical Science, Tabriz, Iran
  2. 2. Cellular and Molecular Biology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  3. 3. Department of Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  4. 4. Department of Molecular Biology and Genetic Engineering, Stem Cell Technology Research Center, Tehran, Iran
  5. 5. Department of Cell, Molecular, and Structural Biology, Miami University, Oxford, OH, United States
  6. 6. Medical Laboratory Sciences Department, Faculty of Para-Medicine, Alborz University of Medical Sciences, Karaj, Iran
  7. 7. Department of Virology, Pasteur Institute of Iran, Tehran, Iran
  8. 8. Department of Hematology, Faculty of Medical Science, Tarbiat Modares University, Tehran, Iran
  9. 9. Drug Applied Research Center, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran

Source: Applied Biochemistry and Biotechnology Published:2017


Abstract

While some microRNAs are transcribed from a specific promoter, at least one third of human miRNA genes are clustered, wherein multiple miRNA genes are generated from a single primary transcript such as miR-17 ~ 92 cluster. Although six members of the cluster are generated from a single transcript, the mature level of each member may be diverse in various cell types. Here, we attempt to monitor the mature level of miR-17, miR-92a, and miR-20a from miR-17 ~ 92 cluster in blood (HL60 (human promyelocytic leukemia cells) and Jurkat) and breast (MDA-MB-231 and MCF-7) cancer cell lines. Interestingly, different mature levels of the miRNAs were observed in each cell line. While miR-20 was highly matured in HL60 and MDA-MB-231 cell lines, higher mature level of miR-92a was observed in Jurkat cell line compared to that of miR-20 and miR-17. Further, the mature level of miRNAs was also measured in normal and cancer cell lines. Although the mature level of miR-17 and miR-92a increased in HL60 and Jurkat cell lines, miR-20 expression showed an almost identical level in blood cancer cell lines compared to controls. Conversely, miR-20 mature level significantly increased in breast cancer cell lines whereas the expression level of miR-92a was comparable in MDA-MB-231, MCF-7, and MCF-10A cell lines. © 2017, Springer Science+Business Media New York.